| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the John Wayne Cancer Institute (TFW, SS, DLM, GJT, DR, WH, LJF, AJB), Santa Monica, California and the Department of Surgery (SS), McLaren Regional Medical Center, Michigan State University, Flint, Michigan.
Correspondence: Address correspondence to: Anton J. Bilchik, MD, PhD, John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404; Fax: 310-449-5261; Email: bilchika{at}jwci.org
Background: The use of lymphatic mapping (LM) is being investigated to improve the staging of colorectal cancer (CRC) and thereby identify patients who might benefit from adjuvant chemotherapy. This study evaluated in vivo, laparoscopic, and ex vivo approaches for the ultrastaging of CRC.
Methods: Seventy-five CRC patients were enrolled in a study of LM with peritumoral injection of isosulfan blue dye. LM was undertaken during open colon resection (OCR) in 64 patients, during laparoscopic colon resection (LCR) in 9 patients, and after specimen removal (ex vivo) in 2 patients. Ex vivo LM was also undertaken in 6 patients after unsuccessful in vivo LM. All nodes were examined by hematoxylin and eosin (H&E) staining; in addition, sentinel lymph nodes (SNs) were multisectioned and examined by immunohistochemical staining with cytokeratin (CK-IHC).
Results: At least one SN was identified in 72 patients (96%). In vivo LM identified SNs in 56 of 64 (88%) patients undergoing OCR and in 9 of 9 (100%) patients undergoing LCR. Ex vivo LM was undertaken as the initial mapping procedure in 2 cases of intraperitoneal colon cancer and after in vivo LM had failed in 6 cases of extraperitoneal rectal carcinoma; an SN was identified in 7 of the 8 cases. Focused examination of the SN correctly predicted nodal status in 53 of 56 OCR cases, 9 of 9 LCR cases, and 6 of 7 ex vivo cases. Multiple sections and CK-IHC identified occult micrometastases in 13 patients (17%), representing 10 OCR, 1 LCR, and 2 ex vivo cases.
Conclusions: LM of drainage from a primary CRC can be accurately performed in vivo during OCR or LCR. Ex vivo LM can be applied when in vivo techniques are unsuccessful and may be useful for rectal tumors. During LCR, colonoscopic injection can be used to mark the primary tumor and define the lymphatic drainage so that adequate resection margins are obtained. These LM techniques improve staging accuracy in CRC.
Key Words: Colorectal carcinoma Sentinel node Lymphatic mapping Staging Laparoscopic colon resection Ex vivo.
This article has been cited by other articles:
![]() |
R. J. de Haas, D. A. Wicherts, M. G. G. Hobbelink, I. H. M. B. Rinkes, M. E. I. Schipper, J.-A. van der Zee, and R. van Hillegersberg Sentinel Lymph Node Mapping in Colon Cancer: Current Status Ann. Surg. Oncol., March 1, 2007; 14(3): 1070 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Bilchik, M. DiNome, S. Saha, R. R. Turner, D. Wiese, M. McCarter, D. S. B. Hoon, and D. L. Morton Prospective Multicenter Trial of Staging Adequacy in Colon Cancer: Preliminary Results Arch Surg, June 1, 2006; 141(6): 527 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Codignola, F. Zorzi, A. Zaniboni, S. Mutti, A. Rizzi, E. Padolecchia, and G. B. Morandi Is there any Role for Sentinel Node Mapping in Colorectal Cancer Staging? Personal Experience and Review of the Literature Jpn. J. Clin. Oncol., November 1, 2005; 35(11): 645 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Smith, J. C. Coffey, N. M. Khasri, M. F. Walsh, N. Parfrey, E. Gaffney, R. Stephens, M. J. Kennedy, W. Kirwan, and H. P. Redmond Sentinel Nodes Are Identifiable in Formalin-Fixed Specimens After Surgeon-Performed Ex Vivo Sentinel Lymph Node Mapping in Colorectal Cancer Ann. Surg. Oncol., June 1, 2005; 12(6): 504 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Dan, S. Saha, K. M. Monson, D. Wiese, E. Schochet, K. R. Barber, B. Ganatra, D. Desai, and S. Kaushal 1% Lymphazurin vs 10% Fluorescein for Sentinel Node Mapping in Colorectal Tumors Arch Surg, November 1, 2004; 139(11): 1180 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zaniboni and R. Labianca Adjuvant therapy for stage II colon cancer: an elephant in the living room? Ann. Onc., September 1, 2004; 15(9): 1310 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ellner, J. Mendez, D. R. Vera, C. K. Hoh, W. L. Ashburn, and A. M. Wallace Sentinel Lymph Node Mapping of the Colon and Stomach Using Lymphoseek in a Pig Model Ann. Surg. Oncol., July 1, 2004; 11(7): 674 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Morton Sentinel Node Mapping and an International Sentinel Node Society: Current Issues and Future Directions Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 137S - 143S. [Full Text] [PDF] |
||||
![]() |
S. Saha, A. G. Dan, A. J. Bilchik, Y. Kitagawa, E. Schochet, S. Choudhri, L. T. Saha, D. Wiese, D. Morton, and M. Kitajima Historical Review of Lymphatic Mapping in Gastrointestinal Malignancies Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 245S - 249S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.E. Le Voyer, E.R. Sigurdson, A.L. Hanlon, R.J. Mayer, J.S. Macdonald, P.J. Catalano, and D.G. Haller Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089 J. Clin. Oncol., August 1, 2003; 21(15): 2912 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Bilchik, D. T. Nora, L. H. Sobin, R. R. Turner, S. Trocha, D. Krasne, and D. L. Morton Effect of Lymphatic Mapping on the New Tumor-Node-Metastasis Classification for Colorectal Cancer J. Clin. Oncol., February 15, 2003; 21(4): 668 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Feezor, E. M. Copeland III, and S. N. Hochwald Significance of Micrometastases in Colorectal Cancer Ann. Surg. Oncol., December 1, 2002; 9(10): 944 - 953. [Full Text] [PDF] |
||||
![]() |
A. J. Bilchik and D. T. Nora Lymphatic Mapping of Nodal Micrometastasis in Colon Cancer: Putting the Cart Before the Horse? Ann. Surg. Oncol., July 1, 2002; 9(6): 529 - 531. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |